Comorbidities of presumed sudden unexpected death participants and national incidence rates
| Per cent | National prevalence (%)* | |
|---|---|---|
| Hypertension | 56.8† | 28.6‡ |
| Diabetes mellitus | 27.4§ | 6.4¶ |
| Dyslipidaemia | 30.5** | 13.8†† |
| Coronary heart disease | 22.1‡‡ | 6.4§§ |
| Cardiomyopathy | 24.2¶¶ | 0.2*** |
Many participant records indicated more than one comorbidity, and all are listed. The percentages were taken of the 95 participants with medical data.
*Data in this column are from source 22.
†Participants with a clinical history of hypertension.
‡Prevalence among adults over 18 years in 2010 .
¶Prevalence among adults >20 with physician-diagnosed diabetes mellitus in 2010.
§Participants with medical records with noted use of antidiabetic medications or clinical history of diabetes mellitus.
**Participants with defined clinical history or use of lipid-lowering medications.
††Hypercholesteraemia prevalence among adults >20.
‡‡Participants with physician noted history of coronary artery bypass grafting, myocardial infarction, pathological Q waves on ECG, history of myocardial infarction, angina or positive stress test results.
§§Coronary heart disease prevalence among adults >20.
¶¶Participants with medical records in which physician report of ischaemic, dilated, hypertrophic or restrictive cardiomyopathy.
***Hypertrophic cardiomyopathy prevalence in US population.